DK26081A - Genetisk svaekkede bakterievacciner med multiple mutationer af samme faenotype - Google Patents

Genetisk svaekkede bakterievacciner med multiple mutationer af samme faenotype

Info

Publication number
DK26081A
DK26081A DK26081A DK26081A DK26081A DK 26081 A DK26081 A DK 26081A DK 26081 A DK26081 A DK 26081A DK 26081 A DK26081 A DK 26081A DK 26081 A DK26081 A DK 26081A
Authority
DK
Denmark
Prior art keywords
genetically
weaked
same phenotype
multiple mutations
bacteria vaccines
Prior art date
Application number
DK26081A
Other languages
English (en)
Other versions
DK161492C (da
DK161492B (da
Inventor
M P Oeschger
J A Bellanti
A M Hooke
Original Assignee
Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corp filed Critical Research Corp
Publication of DK26081A publication Critical patent/DK26081A/da
Publication of DK161492B publication Critical patent/DK161492B/da
Application granted granted Critical
Publication of DK161492C publication Critical patent/DK161492C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/21—Haemophilus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/83—Drug, bio-affecting and body treating compositions involving temperature-sensitive mutant bacterium
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/851—Haemophilus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK026081A 1979-05-23 1981-01-21 Fremgangsmaade til fremstilling af en genetisk svaekket bakterievaccine samt bakteriestamme til brug ved fremgangsmaaden DK161492C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US4189679 1979-05-23
US06/041,896 US4337314A (en) 1979-05-23 1979-05-23 Genetically attenuated bacterial vaccines with multiple mutations of the same phenotype
US8000613 1980-05-23
PCT/US1980/000613 WO1980002504A1 (en) 1979-05-23 1980-05-23 Genetically attenuated bacterial vaccines with multiple mutations of the same phenotype

Publications (3)

Publication Number Publication Date
DK26081A true DK26081A (da) 1981-01-21
DK161492B DK161492B (da) 1991-07-15
DK161492C DK161492C (da) 1992-01-13

Family

ID=21918924

Family Applications (1)

Application Number Title Priority Date Filing Date
DK026081A DK161492C (da) 1979-05-23 1981-01-21 Fremgangsmaade til fremstilling af en genetisk svaekket bakterievaccine samt bakteriestamme til brug ved fremgangsmaaden

Country Status (9)

Country Link
US (1) US4337314A (da)
EP (1) EP0024956B1 (da)
JP (1) JPH0440330B2 (da)
AU (1) AU536370B2 (da)
DE (1) DE3071115D1 (da)
DK (1) DK161492C (da)
IE (1) IE50598B1 (da)
NZ (1) NZ193815A (da)
WO (1) WO1980002504A1 (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837151A (en) * 1980-05-19 1989-06-06 The Board Of Trustees Of The Leland Stanford Junior University, Stanford University Live vaccines comprising two mutations and foreign antigen
US5643771A (en) * 1980-05-19 1997-07-01 The Board Of Trustees Of The Leland Stanford Junior University Non-reverting live bacterial vaccines
US4550081A (en) * 1980-05-19 1985-10-29 The Board Of Trustees Of The Leland Stanford Jr. University Non-reverting salmonella
US4735801A (en) * 1982-09-07 1988-04-05 Board Of Trustees Of Leland Stanford Jr. University Novel non-reverting salmonella live vaccines
WO1982003088A1 (en) * 1981-03-09 1982-09-16 Corp Cetus Vaccines
US5137721A (en) * 1981-03-09 1992-08-11 Cetus Corporation Employing strains of E. coli expressing non-indigenous adhesins and toxoids of E. coli
US4559306A (en) * 1981-04-17 1985-12-17 Norden Laboratories, Inc. Modified Pasteurella multocida bacteria
US4554159A (en) * 1981-11-12 1985-11-19 Institute Merieux Vaccine and method of immunizing against herpes simplex virus (types 1 and 2)
US5135739A (en) * 1983-02-15 1992-08-04 Kitasato Kenkyusho Non-cariogenic composition and drink
US4857318A (en) * 1983-11-07 1989-08-15 Syntex (U.S.A.) Inc. Bordetella bronchiseptica pilus subunit protein vaccine effective against bordetella pertussis
US4764370A (en) * 1984-09-12 1988-08-16 Scripps Clinic And Research Foundation Vaccine utilizing an avirulent strain of Salmonella typhimurium
US4873090A (en) * 1985-03-27 1989-10-10 Broncostat Pty. Limited Non-adjuvenated vaccine
WO1986006279A1 (en) * 1985-04-30 1986-11-06 Scripps Clinic And Research Foundation Acute phase protein modulating endotoxic activity of lipopolysaccharides, compositions and methods
NZ224422A (en) * 1987-05-05 1990-11-27 Molecular Eng Ass Composition adapted for intranasal immunisation against viral infection comprising a glycoprotein complexed with a lipid
US5811105A (en) * 1987-12-23 1998-09-22 Glaxo Wellcome, Inc. Vaccines containing bacteria attenuated by mutations in two genes of the aromatic amino acid biosynthetic pathway
GB8730037D0 (en) * 1987-12-23 1988-02-03 Wellcome Found Vaccines
US4891210A (en) * 1989-01-03 1990-01-02 Norris Alan H Use of bacteriophages in dental hygiene
US5132220A (en) * 1989-06-30 1992-07-21 The United States Of America As Represented By The Secretary Of Agriculture More virulent biotype isolated from wild-type virus
US4957686A (en) * 1990-02-06 1990-09-18 Norris Alan H Use of bacteriophages to inhibit dental caries
GB9007194D0 (en) * 1990-03-30 1990-05-30 Wellcome Found Live vaccines
DE4041045A1 (de) * 1990-12-20 1992-07-02 Max Planck Gesellschaft Zweiphasen-systeme fuer die produktion und praesentation von fremdantigen in hybriden lebendimpfstoffen
CA2101550A1 (en) * 1991-01-29 1992-07-30 Kakambi V. Nagaraja Live vaccine against colibacillosis
EP0668779A4 (en) * 1992-11-06 1996-08-21 Univ Minnesota Vaccine to protect against pasteurellosis - infection by P.multocida.
US6254874B1 (en) 1995-04-13 2001-07-03 President And Fellows Of Harvard College Attenuated auxotrophic microorganisms having a combination of non-attenuating mutations and method for making same
US5741680A (en) * 1996-09-03 1998-04-21 Cera Products, Inc. Buffer composition base and method of formulation for oral vaccine delivery
US20060140975A1 (en) * 2002-09-01 2006-06-29 Curtiss Roy Iii Regulated bacterial lysis for gene vaccine vector delivery and antigen release
US8637049B2 (en) * 2011-04-06 2014-01-28 The United States Of America, As Represented By The Secretary Of Agriculture Attenuated live vaccines for aquatic animals

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856935A (en) * 1971-04-29 1974-12-24 Schweiz Serum & Impfinst Oral typhoid vaccine and method of preparing the same
US3975517A (en) * 1972-05-25 1976-08-17 Canadian Patents And Development Limited Enteric disease vaccine
US3992522A (en) * 1973-01-24 1976-11-16 The United States Of America As Represented By The Department Of Health, Education And Welfare Temperature-sensitive recombinant mutant viruses and a process for producing same
US4058599A (en) * 1973-02-24 1977-11-15 Bayer Aktiengesellschaft Ethyleneimine inactivated organisms
US3855408A (en) * 1973-07-16 1974-12-17 Univ Minnesota Poultry vaccine
US4190495A (en) 1976-09-27 1980-02-26 Research Corporation Modified microorganisms and method of preparing and using same
IL52815A (en) * 1977-08-24 1983-03-31 Israel State Fowl cholera vaccine and process for producing an attenuated non-virulent strain of pasteurella multocida
US4133875A (en) * 1978-02-23 1979-01-09 Forsyth Dental Infirmary For Children Method of controlling dental caries with streptococcus mutans mutant strains

Also Published As

Publication number Publication date
IE50598B1 (en) 1986-05-28
EP0024956B1 (en) 1985-09-25
AU5855680A (en) 1980-11-27
US4337314A (en) 1982-06-29
EP0024956A2 (en) 1981-03-11
WO1980002504A1 (en) 1980-11-27
JPH0440330B2 (da) 1992-07-02
IE801073L (en) 1980-11-23
DK161492C (da) 1992-01-13
DK161492B (da) 1991-07-15
AU536370B2 (en) 1984-05-03
JPS56500612A (da) 1981-05-07
DE3071115D1 (en) 1985-10-31
EP0024956A3 (en) 1981-12-02
NZ193815A (en) 1982-12-21

Similar Documents

Publication Publication Date Title
DK26081A (da) Genetisk svaekkede bakterievacciner med multiple mutationer af samme faenotype
KR970009347B1 (en) Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3
IT1190792B (it) Procedimento per preparare composizioni di enzimi coagulanti del sangue
IT1131776B (it) Protesi anulare regolabile per chirurgia cardiaca
DZ634A1 (fr) Mutants de vibrio cholerale non-toxinogènes.
CH614718A5 (en) Process for the preparation of glucosamine derivatives
MX9303992A (es) Mutantes de eliminacion como vacunas para el colera.
ES2244617T3 (es) Vacunas a base de salmonelas en las cuales los genes ssa han sido inactivados.
ES490210A0 (es) Un procedimiento par la preparacion de una vacuna de la gri-pe.
IT1209378B (it) Procedimento per preparare copolimeri.
DK437980A (da) Felin infektioest peritonitis-virum og vacciner fremstillet deraf
ATE297218T1 (de) Impfstoff gegen mehrere fiv-subtypen
ES467557A1 (es) Un procedimiento para la preparacion de una nueva vacuna queprotege a las aves ponedoras de huevos contra la enfermedad del descenso de la produccion de huevos.
WO1992006113A3 (en) Derivatives of gp160 and vaccines based on gp160 or a derivative thereof, containing an adjuvant
AU522338B2 (en) Vaccine adjuvants
IE38423L (en) Neonatal calf diarrhea vaccine.
NO913131L (no) Immunogene konjugater av ikke-toksisk oligosakkarid fra bordetella pertussis lipoolysakkarid.
BE827900A (fr) Procede en vue d'immuniser des gorets allaites contre le virus de la gastro-enterite transmissible
ES487062A0 (es) Procedimiento para preparar una vacuna inactivada de reo-vi-rus
PT636030E (pt) Vacina de bacterina-toxoide de pasteurella haemolytica tipo a-1
FR2462166B1 (fr) Compositions antigeniques, leur preparation et vaccins a base de ces compositions
DK52783D0 (da) Vaccine indeholdende en ozoninaktiveret mikroorganisme og fremgangsmade til fremstilling af en sadan vaccine
SU979504A1 (ru) Щтамм НАГ-фага 93,Ф-98,лизирующий НАГ-вибрионы 0-8 серотипа
RO79877A (ro) Procedeu pentru obtinerea unor tulpini bacteriene inalt imunogene
ES485474A0 (es) Procedimiento de obtencion del 4,4-(isopropilidenditio)-bis-(2,6-di-t-butilfenol)

Legal Events

Date Code Title Description
PUP Patent expired